Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Alimentary Pharmacology & Therapeutics (Suppl) Année : 2019

Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients

Ailsa Hart
  • Fonction : Auteur
  • PersonId : 887140

Résumé

The nocebo effect is a negative effect of a pharmacological or nonpharmacological medical treatment that is induced by patients' expectations, and that is unrelated to the physiological action of the treatment. The nocebo effect can negatively affect treatment outcomes.
Fichier non déposé

Dates et versions

hal-02923063 , version 1 (26-08-2020)

Identifiants

Citer

Lieven Pouillon, Silvio Danese, Ailsa Hart, Gionata Fiorino, Marjorie Argollo, et al.. Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients. Alimentary Pharmacology & Therapeutics (Suppl), 2019, 49 (9), pp.1181-1187. ⟨10.1111/apt.15223⟩. ⟨hal-02923063⟩
46 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More